Immunis, Inc.
Immunomodulatory therapeutics targeting age-related disease mechanisms
- Sector
- Biotech
- Headquarters
- Irvine, CA
- Latest Form D
- $12M, Jun 2026
- Total capital
- $27.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $27.8M
- 2 Form D · last Jun 2026
- 4 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$12M
- Private capital raisedForm D · SEC · 1st filing$15.8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Daniel KraftDirectorNamed in SEC Form D filings
- Gabriel NistorExecutive OfficerNamed in SEC Form D filings
- Hans KeirsteadExecutive Officer, DirectorNamed in SEC Form D filings
- Takahide KodaDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingMethods Of Preparation Of Secretomes, And Uses ThereofUSPTOApplication 18274426
- PendingMolecular Superstructure And Methods Of Use ThereofUSPTOApplication 18274195
- PendingMethod Of Making And Using Secretome CompositionUSPTOApplication PCTUS2025020578
Show all 6 patent records
- Methods Of Preparation Of Secretomes, And Uses ThereofOct 23, 2025 · Application 18274426Pending
- Molecular Superstructure And Methods Of Use ThereofMar 28, 2024 · Application 18274195Pending
- Method Of Making And Using Secretome CompositionApplication PCTUS2025020578Pending
- Secretome Composition And UsesApplication 63567351Pending
- Methods Of Preparation Of Secretomes, And Uses ThereofApplication PCTUS2022013834Pending
- Molecular Superstructure And Methods Of Use ThereofApplication PCTUS2022013706Pending
Related companies, and why
- Clover Biopharmaceuticals, Ltd.Similar federal contract value in Biotech · null in contracts
- Carterra, Inc.Similar federal contract value in Biotech · null in contracts
- ACCELERO BIOSTRUCTURES INCSimilar federal contract value in Biotech · null in contracts
- Shift Pharmaceuticals Holdings, Inc.Similar federal contract value in Biotech · null in contracts
- Caradon Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- NEUTROLIS, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .